Characterization of Choline and Ethanolamine Kinase Activities in Plasmodium — Infected Erythrocytes

  • Marie L. Ancelin
  • Henri J. Vial
  • Jean R. Philippot
Part of the NATO ASI Series book series (NSSA, volume 116)


Mature mammalian erythrocytes lack the enzymatic machinery for synthesizing lipids and there is no net synthesis of major phospholipids (PL). The turnover can be attributed to two main processes: the exchange of PL between plasma lipoproteins and membrane, or the acylation of lyso-phosphatidylcholine, originating from the surrounding plasma and possibly from membrane (1). The synthesis of phosphatidylcholine (PC) by N-methylation of phosphatidylethanolamine (PE) is of minor importance in supplying the cellular PC requirements, but could play a role in transmitting signals acting via cell surface receptors (2).


Infected Erythrocyte Choline Kinase Kennedy Pathway Choline Phosphotransferase Saponin Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. L. Van Deenen and J. De Gier, in “The Red Blood Cell” (Surgenor, DMC ed., pp 147–214, Academic Press, New-York (1974).Google Scholar
  2. 2.
    F. Hirata and J. Axelrod, Science 209: 1082 (1980).PubMedCrossRefGoogle Scholar
  3. 3.
    G. G. Holz, Bull. W.H.O. 55: 235 (1977).Google Scholar
  4. 4.
    H. J. Vial, M. J. Thuet and J. R. Philippot, J. Parasitol. 68: 379 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    T. L. Perry, S. Hansen and R. G. Christie, Biol. Psychiatry 13: 573 (1978).Google Scholar
  6. 6.
    S. B. Jensen and W. Trager, J. Parasitol. 63: 883 (1977).PubMedCrossRefGoogle Scholar
  7. 7.
    R. M. Bell and R. A. Coleman, Ann. Rev. Biochem. 49: 459 (1980).PubMedCrossRefGoogle Scholar
  8. 8.
    H. J. Vial, M. J. Thuet and J. R. Philippot, Biochim. Biophys. Acta 795: 372 (1984).CrossRefGoogle Scholar
  9. 9.
    H.J. Vial, M. J. Thuet, M.L. Ancelin, J. R. Philippot and C. Chavis, Biochem. Pharmacol. 33 (17): 2761 (1984).PubMedCrossRefGoogle Scholar
  10. 10.
    M. Spector and W. W. Cleland, Biochem. Pharmacol. 30: 1 (1981).PubMedCrossRefGoogle Scholar
  11. 11.
    M. Hanza, J. Lloveras, G. Ribbes, G. Soula and L. Douste Blazy, Biochem. Pharmacol. 32: 1893 (1983).CrossRefGoogle Scholar
  12. 12.
    M. L. Ancelin and H. J. Vial, Biochim. Biophys. Acta, in the press.Google Scholar
  13. 13.
    R. T. Cook, M. Aikawa, R. C. Rock, W. Little and H. Spring, Milit. Med. 134: 866 (1969).Google Scholar
  14. 14.
    D. F. H. Wallach and R. Schmidt-Ullrich, Methods in Cell Biology 15: 253 (1976).Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Marie L. Ancelin
    • 1
  • Henri J. Vial
    • 1
  • Jean R. Philippot
    • 1
  1. 1.CNRS U.A. 530, INSERM U.58MontpellierFrance

Personalised recommendations